Blood and urine biomarkers in chronic kidney disease: An update

Published on Aug 1, 2019in Clinica Chimica Acta2.735
· DOI :10.1016/j.cca.2019.04.069
Mohammad Zulkarnain Bidin1
Estimated H-index: 1
(UPM: Universiti Putra Malaysia),
Anim Md. Shah1
Estimated H-index: 1
(UPM: Universiti Putra Malaysia)
+ 1 AuthorsChristopher Lim Thiam Seong1
Estimated H-index: 1
(UPM: Universiti Putra Malaysia)
Abstract Introduction Chronic kidney disease (CKD) is a silent disease. Most CKD patients are unaware of their condition during the early stages of the disease which poses a challenge for healthcare professionals to institute treatment or start prevention. The trouble with the diagnosis of CKD is that in most parts of the world, it is still diagnosed based on measurements of serum creatinine and corresponding calculations of eGFR. There are controversies with the current staging system, especially in the methodology to diagnose and prognosticate CKD. Objective The aim of this review is to examine studies that focused on the different types of samples which may serve as a good and promising biomarker for early diagnosis of CKD or to detect rapidly declining renal function among CKD patient. Method The review of international literature was made on paper and electronic databases Nature, PubMed, Springer Link and Science Direct. The Scopus index was used to verify the scientific relevance of the papers. Publications were selected based on the inclusion and exclusion criteria. Result 63 publications were found to be compatible with the study objectives. Several biomarkers of interest with different sample types were taken for comparison. Conclusion Biomarkers from urine samples yield more significant outcome as compare to biomarkers from blood samples. But, validation and confirmation with a different type of study designed on a larger population is needed. More comparison studies on different types of samples are needed to further illuminate which biomarker is the better tool for the diagnosis and prognosis of CKD.
  • References (103)
  • Citations (0)
📖 Papers frequently viewed together
8 Citations
2 Citations
5 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Flaviu BobH-Index: 13
#2Adalbert SchillerH-Index: 12
Last. Adrian Covic (Grigore T. Popa University of Medicine and Pharmacy)H-Index: 61
view all 15 authors...
Abstract Background Klotho is found in two forms: a transmembrane form and a soluble form (s-Klotho). In order to be excreted, s-Klotho, that is too large to be filtered, will probably reach the proximal convoluted tubule by a transcytosis process. The aim of our study was to show the relationship between the levels of s-Klotho and tubular injury in patients with diabetic kidney disease (DKD), using as tubular injury marker the kidney injury molecule-1 (KIM-1). Methods Our study included 63 DKD ...
1 CitationsSource
#1Petter Bjornstad (University of Colorado Denver)H-Index: 20
#2Pattara Wiromrat (University of Colorado Denver)H-Index: 2
Last. Janet K. Snell-Bergeon (University of Colorado Denver)H-Index: 38
view all 8 authors...
OBJECTIVE Novel biomarkers are needed to better predict coronary artery calcification (CAC), a marker of subclinical atherosclerosis, and diabetic kidney disease (DKD) in type 1 diabetes. We evaluated the associations between serum uromodulin (SUMOD [a biomarker associated with anti-inflammatory and renal protective properties]), CAC progression and DKD development over 12 years. RESEARCH DESIGN AND METHODS Participants (n = 527, 53% females) in the Coronary Artery Calcification in Type 1 Diabet...
5 CitationsSource
#1Kinsuk Chauhan (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 8
#2Divya A. Verghese (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 6
Last. Girish N. Nadkarni (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 25
view all 7 authors...
Novel biomarkers are needed to predict kidney function decline in patients with type 2 diabetes, especially those with preserved glomerular filtration rate (GFR). There are limited data on the association of markers of endothelial dysfunction with longitudinal GFR decline. We used banked specimens from a nested case-control study in the Action to Control Cardiovascular Disease (ACCORD) trial (n=187 cases: 187 controls) and from a diverse contemporary cohort of type 2 diabetic patients from the M...
1 CitationsSource
#1Mariam Alam (UW: University of Washington)H-Index: 2
#2Ronit Katz (UW: University of Washington)H-Index: 61
Last. Nisha Bansal (UW: University of Washington)H-Index: 18
view all 16 authors...
Introduction Cardiac biomarkers soluble ST2 (sST2) and galectin-3 may reflect cardiac inflammation and fibrosis. It is plausible that these mechanisms may also contribute to the progression of kidney disease. We examined associations of sST2 and galectin-3 with kidney function decline in participants with chronic kidney disease (CKD). Methods This was a pooled analysis of 2 longitudinal cohorts of participants with CKD: the Clinical Phenotyping and Resource Biobank (C-PROBE) study and the Seattl...
5 CitationsSource
#1Marco Colombo (Edin.: University of Edinburgh)H-Index: 11
#2Helen C. Looker (Dund.: University of Dundee)H-Index: 21
Last. Helen M. Colhoun (Western General Hospital)H-Index: 62
view all 18 authors...
Aims/hypothesis As part of the Surrogate Markers for Micro- and Macrovascular Hard Endpoints for Innovative Diabetes Tools (SUMMIT) programme we previously reported that large panels of biomarkers derived from three analytical platforms maximised prediction of progression of renal decline in type 2 diabetes. Here, we hypothesised that smaller (n ≤ 5), platform-specific combinations of biomarkers selected from these larger panels might achieve similar prediction performance when tested in three a...
7 CitationsSource
#1William R. ZhangH-Index: 7
#2Timothy E. Craven (Wake Forest University)H-Index: 46
Last. Joachim H. Ix (UCSD: University of California, San Diego)H-Index: 59
view all 10 authors...
Background:Whether the increased incidence of chronic kidney disease (CKD) during intensive systolic blood pressure (SBP) lowering is accompanied by intrinsic kidney injury is unknown.Objective:To compare changes in kidney damage biomarkers between incident CKD case participants and matched control
8 CitationsSource
#1Ye Feng (SEU: Southeast University)H-Index: 7
#2Lin-Li Lv (SEU: Southeast University)H-Index: 21
Last. Bi-Cheng Liu (SEU: Southeast University)H-Index: 27
view all 13 authors...
IgA nephropathy (IgAN) features variable renal pathology and a heterogeneous clinical course. Our aim was to search noninvasive biomarkers from urinary exosomes for IgAN patients; membrane nephropathy and minimal change disease were included as other glomerulopathy controls. Transmission electron microscopy and nanoparticle tracking analysis confirmed the size and morphology characteristic of urinary exosomes. Exosome markers (Alix and CD63) as well as renal cell markers [aquaporin 2 (AQP2) and ...
5 CitationsSource
#1Maria E. Rodríguez-Ortiz (UAM: Autonomous University of Madrid)H-Index: 12
#2Claudia PontilloH-Index: 10
Last. Alberto Ortiz (UAM: Autonomous University of Madrid)H-Index: 75
view all 6 authors...
Chronic kidney disease is associated with increased risk of CKD progression and death. Therapeutic approaches to limit progression are limited. Developing tools for the early identification of those individuals most likely to progress will allow enriching clinical trials in high risk early CKD patients. The CKD273 classifier is a panel of 273 urinary peptides that enables early detection of CKD and prognosis of progression. We have generated urine capillary electrophoresis-mass spectrometry-base...
5 CitationsSource
#1Liang WuH-Index: 3
#2Xiao-Qian LiH-Index: 3
Last. Ming-Hui ZhaoH-Index: 40
view all 9 authors...
Background: In diabetic kidney disease (DKD), it is important to find biomarkers for predicting initiation and progression of the disease. Besides glomerular damage, kidney tubular injury and inflammation are also involved in the development of DKD. The current study investigated the associations of urinary epidermal growth factor (uEGF), monocyte chemotactic protein-1 (MCP-1) and the uEGF:MCP-1 ratio with kidney involvement in patients at early and advanced stages of DKD. Methods: The concentra...
4 CitationsSource
#1Stephen Zewinger (Saarland University)H-Index: 11
#2Thomas RauenH-Index: 35
Last. Thimoteus Speer (Saarland University)H-Index: 16
view all 16 authors...
Background The individual course of CKD may vary, and improved methods for identifying which patients will experience short-term eGFR loss are needed. Assessing urinary Dickkopf-3 (DKK3), a stress-induced tubular epithelia–derived profibrotic glycoprotein, may provide information about ongoing tubulointerstitial fibrosis and short-term eGFR loss. Methods To investigate urinary DKK3’s potential as a biomarker of short-term eGFR loss (over 12 months), we prospectively assessed eGFR and urinary DKK...
4 CitationsSource
Cited By0
#1Hanfei Shen (UPenn: University of Pennsylvania)
#2Tony Liu (UPenn: University of Pennsylvania)
Last. David Issadore (UPenn: University of Pennsylvania)H-Index: 25
view all 7 authors...
Liquid biopsy (LB) technologies continue to improve in sensitivity, specificity, and multiplexing and can measure an ever growing library of disease biomarkers. However, clinical interpretation of the increasingly large sets of data these technologies generate remains a challenge. Machine learning is a popular approach to discover and detect signatures of disease. However, limited machine learning expertise in the LB field has kept the discipline from fully leveraging these tools and risks impro...
#1Manousos Makridakis (Academy of Athens)H-Index: 15
#2Georgia Kontostathi (Academy of Athens)H-Index: 5
Last. Jerome Zoidakis (Academy of Athens)H-Index: 12
view all 11 authors...
Current diagnostic measures for Chronic Kidney Disease (CKD) include detection of reduced estimated glomerular filtration rate (eGFR) and albuminuria, which have suboptimal accuracies in predicting disease progression. The disease complexity and heterogeneity underscore the need for multiplex quantification of different markers. The goal of this study was to determine the association of six previously reported CKD-associated plasma proteins [B2M (Beta-2-microglobulin), SERPINF1 (Pigment epitheli...
#1Dmitry Belyaev (TUD: Dresden University of Technology)
#2Julian Schütt (TUD: Dresden University of Technology)H-Index: 3
Last. Gianaurelio Cuniberti (TUD: Dresden University of Technology)H-Index: 48
view all 6 authors...
: Here, we present a miniaturized lab-on-a-chip detecting system for an all-electric and label-free analysis of the emulsion droplets incorporating the nanoscopic silicon nanowires-based field-effect transistors (FETs). We specifically focus on the analysis of β-galactosidase e.g.activity, which is an important enzyme of the glycolysis metabolic pathway. Furthermore, the efficiency of the synthesis and action of β-galactosidase can be one of the markers for several diseases, e.g., cancer, hyper/...
Background The information concerning non-invasive, easily obtainable, and accurate biomarkers for diagnosis of lupus nephritis (LN) is extremely limited. The aim of this study was to evaluate the diagnostic performance of cystatin C (CysC) and complement component 1q (C1q) for LN.